Anti-aging properties of metformin
DOI:
https://doi.org/10.12775/JEHS.2021.11.09.005Keywords
metformin, anti-aging, agingAbstract
Introduction: Life expectancy of human population is being constantly prolonged, hence there is a lot of research into drug that will prevent the effects of aging. There are many reports that metformin, which is a drug used in type 2 diabetes, has anti-aging effects. It belongs to the group of biguanides and has been used since the 1950s. It is a relatively safe, cheap and effective drug, which makes it a promising subject for many studies. The purpose of this review is to present the latest developments in this field.
Material and methods: PubMed scientific base was searched using following keywords: metformin, aging, anti-aging, in years 2017-2021.
Results: Numerous studies show that metformin has an impact on aging through the nutrient pathway, AMPK signaling pathway, and its effects on reactive oxygen species. In addition, it has an anti-cancer effect, inhibiting, among others, rectal cancer cells and p53 mutant colon cancer. Research in rodents has shown that this drug has anti-aging effects on many organs, including the CNS, ovaries, prostate, heart muscle and skin.
Conclusions: Metformin, which is the most commonly used oral drug in type 2 diabetes, has many other mechanisms of action. Its anti-aging effect works on many organs in our bodies, which gives hope to find an anti-aging substance. However, multicentre, randomized trials are needed to determine the exact anti-aging dose, its possible side effects, and effects on various organisms.
References
T. Flatt and L. Partridge; Horizons in the evolution of aging; BMC Biol. 2018; 16: 93. doi: 10.1186/s12915-018-0562-z.
J. Flory and K. Lipska; Metformin in 2019; JAMA. 2019 May 21; 321(19): 1926–1927. doi: 10.1001/jama.2019.3805.
D. L. Palliyaguru et al. Frailty index as a biomarker of lifespan and healthspan: focus on pharmacological interventions; Mech Ageing Dev. 2019 Jun; 180: 42–48. doi: 10.1016/j.mad.2019.03.005.
M. V. Blagosklonny; From rapalogs to anti-aging formula; Oncotarget. 2017 May 30; 8(22): 35492–35507. doi: 10.18632/oncotarget.18033.
J. A. Menendez; Metformin: Sentinel of the Epigenetic Landscapes That Underlie Cell Fate and Identity; Biomolecules. 2020 May; 10(5): 780. doi: 10.3390/biom10050780.
D. Hu et al. Metformin: A Potential Candidate for Targeting Aging Mechanisms Agin; Dis. 2021 Apr; 12(2): 480–493. doi: 10.14336/AD.2020.0702.
Z. Li et al. Aging and age‐related diseases: from mechanisms to therapeutic strategies; Biogerontology. 2021 Jan 27 : 1–23. doi: 10.1007/s10522-021-09910-5.
J. Yang et al. Identification of human age-associated gene co-expressions in functional modules using liquid association; Oncotarget. 2018 Jan 2; 9(1): 1063–1074. doi: 10.18632/oncotarget.23148.
L. Jiang and L. Liu; Effect of metformin on stem cells: Molecular mechanism and clinical prospect; World J Stem Cells. 2020 Dec 26; 12(12): 1455–1473. doi: 10.4252/wjsc.v12.i12.1455.
M. Kodali et al. Metformin treatment in late middle age improves cognitive function with alleviation of microglial activation and enhancement of autophagy in the hippocampus; Aging Cell. 2021 Feb; 20(2): e13277. doi: 10.1111/acel.13277.
X. Zhu et al. Metformin improves cognition of aged mice by promoting cerebral angiogenesis and neurogenesis; Aging (Albany NY). 2020 Sep 30; 12(18): 17845–17862. doi: 10.18632/aging.103693.
C. Li et al. Metformin mediates cardioprotection against aging‐induced ischemic necroptosis; Aging Cell. 2020 Feb; 19(2): e13096. doi: 10.1111/acel.13096.
X. Qin et al. Metformin prevents murine ovarian aging; Aging (Albany NY). 2019 Jun 15; 11(11): 3785–3794. doi: 10.18632/aging.102016.
Y. Hong et al. The preventive effect of metformin on progression of benign prostate hyperplasia: A nationwide population-based cohort study in Korea; PLoS One. 2019; 14(7): e0219394. doi: 10.1371/journal.pone.0219394.
P. Zhao et al. Anti‐aging pharmacology in cutaneous wound healing: effects of metformin, resveratrol, and rapamycin by local application; Aging Cell. 2017 Oct; 16(5): 1083–1093. doi: 10.1111/acel.12635.
C. Kremslehner et al. Imaging of metabolic activity adaptations to UV stress, drugs and differentiation at cellular resolution in skin and skin equivalents – Implications for oxidative UV damage; Redox Biol. 2020 Oct; 37: 101583. doi: 10.1016/j.redox.2020.101583.
A. A. Soukas, H. Hao and L. Wu; Metformin as Anti-Aging Therapy: Is It for Everyone? Trends Endocrinol Metab. 2019 Oct; 30(10): 745–755. doi: 10.1016/j.tem.2019.07.015.
C. Wang et al. Clinical perspectives and concerns of metformin as an anti‐aging drug; Aging Med (Milton). 2020 Dec; 3(4): 266–275. doi: 10.1002/agm2.12135.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 © The Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 385
Number of citations: 0
